Bone marrow mesenchymal stem cells

DRUG3 trials

Sponsors

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia, Universidad Catolica Santiago de Guayaquil, Taiwan Bio Therapeutics Inc.

Conditions

Idiopathic Interstitial PneumoniaIdiopathic Pulmonary FibrosisInterstitial Lung DiseaseOsteo Arthritis KneeOsteoarthritis, Knee

Phase 1

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

CompletedNCT02594839

Federal Research Clinical Center of Federal Medical & Biological Agency, RussiaIdiopathic Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Start: 2013-02-28End: 2018-01-31Updated: 2018-01-09

Phase 2

Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)

CompletedNCT05027581

Taiwan Bio Therapeutics Inc.Osteoarthritis, Knee

Start: 2021-10-13End: 2025-06-04Updated: 2026-07-06

Phase 3

Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis

Universidad Catolica Santiago de GuayaquilOsteo Arthritis Knee

Start: 2020-06-07End: 2021-09-07Target: 54Updated: 2020-04-17